| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.007 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.12 | 0.008 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.14 | 0.008 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.092 | 0.008 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.14 | 0.008 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.008 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.009 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |